Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006)

PURPOSE: In this trial, we investigated the efficacy and safety of adjuvant letrozole for hormone receptor (HR)-positive breast cancer. Here, we report the clinical outcome in postmenopausal women with HR-positive breast cancer treated with adjuvant letrozole according to estrogen receptor (ER) expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Sung Gwe, Nam, Seok Jin, Ahn, Sei Hyun, Jung, Yongsik, Park, Heung Kyu, Lee, Soo Jung, Kang, Sung Soo, Han, Wonshik, Park, Kyong Hwa, Park, Yong Lai, Lee, Jihyoun, Youn, Hyun Jo, Kim, Jun Hyun, Yoo, Youngbum, Song, Jeong-Yoon, Ko, Byung Kyun, Gwak, Geumhee, Chung, Min Sung, Kim, Sung Yong, Cho, Seo Heon, Kim, Doyil, Chang, Myung-Chul, Moon, Byung In, Kim, Lee Su, Kim, Sei Joong, Park, Min Ho, Kim, Tae Hyun, Cho, Jihyoung, Lim, Cheol Wan, Bae, Young Tae, Gong, Gyungyub, Bae, Young Kyung, Lee, Ahwon, Jeong, Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090806/
https://www.ncbi.nlm.nih.gov/pubmed/33818022
http://dx.doi.org/10.4048/jbc.2021.24.e17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090806/
https://www.ncbi.nlm.nih.gov/pubmed/33818022
http://dx.doi.org/10.4048/jbc.2021.24.e17

Ejemplares similares